• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Five Prime Therapeutics Inc

+ Add to Watchlist


11.9100 USD 0.4000 3.48%

As of 20:10:00 ET on 09/16/2014.

Snapshot for Five Prime Therapeutics Inc (FPRX)

Open: 12.0300 Day's Range: 11.6174 - 12.4430 Volume: 59,008
Previous Close: 11.5100 52wk Range: 8.0200 - 23.3300 1-Yr Rtn: -8.38%

Stock Chart for FPRX

No chart data available.
  • FPRX:US 11.9350
  • 1D
  • 1M
  • 1Y
Interactive FPRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FPRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -4.0900
Est. EPS (USD) (12/2014) -1.7050
Est. PEG Ratio -
Market Cap (M USD) 256.31
Shares Outstanding (M) 21.52
30 Day Average Volume 112,979
Price/Book (mrq) 2.5401
Price/Sale (ttm) 6.0594
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FPRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FPRX

Five Prime Therapeutics, Inc. provides clinical stage biotechnology services. The Company offers innovative protein and antibody therapeutics, as well as offers drugs for oncology and immunology diseases. FivePrime Therapeutics conducts serves customers in the United States.

Lewis T Williams "Rusty"President/CEO/Co-FounderMarc L BelskySenior VP/CFO
Julie HambletonSenior VP/Chief Medical OfcrAron M KnickerbockerSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for FPRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil